Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse NMDAR2A ELISA Kit (AC3331)
Cat.#: ASET-1920
Specifications
Description Mouse NMDAR2A ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse NMDAR2A concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.62 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1146 Human Urocortin ELISA Kit (AC2557) Quantitative inquiry ASET-1904 Mouse Syndecan-1 ELISA Kit (AC3315) Quantitative inquiry ASET-1421 Porcine VCAM1 ELISA Kit (AC2832) Quantitative inquiry ASET-2046 Human Activin B ELISA Kit (AC3457) Quantitative inquiry ASET-1077 Human KCNAB2 ELISA Kit (AC2488) Quantitative inquiry ASET-1701 Rat CACNA1A ELISA Kit (AC3112) Quantitative inquiry ASET-1905 Human Myelin Basic Protein ELISA Kit (AC3316) Quantitative inquiry ASET-1832 Human NCAM1 ELISA Kit (AC3243) Quantitative inquiry ASET-1460 Mouse VGLUT2 ELISA Kit (AC2871) Quantitative inquiry ASET-1698 Human Copeptin ELISA Kit (AC3109) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket